Dr. Zunt served as principal investigator in a study funded by Parion Sciences.
Sjögren's Syndrome
Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial†
Article first published online: 28 DEC 2010
DOI: 10.1002/art.27766
Copyright © 2011 by the American College of Rheumatology
Additional Information
How to Cite
Strietzel, F. P., Lafaurie, G. I., Mendoza, G. R. B., Alajbeg, I., Pejda, S., Vuletić, L., Mantilla, R., Falcão, D. P., Leal, S. C., Bezerra, A. C. B., Tran, S. D., Ménard, H. A., Kimoto, S., Pan, S., Martín-Granizo, R. A., Lozano, M. L. M., Zunt, S. L., Krushinski, C. A., Melilli, D., Campisi, G., Paderni, C., Dolce, S., Yepes, J. F., Lindh, L., Koray, M., Mumcu, G., Elad, S., Zeevi, I., Barrios, B. C. A., López Sánchez, R. M., Beiski, B. Z., Wolff, A. and Konttinen, Y. T. (2011), Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial. Arthritis & Rheumatism, 63: 180–190. doi: 10.1002/art.27766
- †
ClinicalTrials.gov identifier: NCT00509808.
Publication History
- Issue published online: 28 DEC 2010
- Article first published online: 28 DEC 2010
- Accepted manuscript online: 29 SEP 2010 01:52PM EST
- Manuscript Accepted: 21 SEP 2010
- Manuscript Received: 14 APR 2010
Funded by
- Canadian Institutes of Health Research to McGill University (CIHR Program to Stimulate International Research Initiatives)
- Swedish Laryng Foundation to Malmö University
- Academy of Finland
- Finska Läkaresällskapet
- Helsinki University Central Hospital
- ORTON Foundation to the University of Helsinki. Saliwell Ltd. (Harutzim, Israel)
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2012, 113, 6, 773
- 2, , , , Sjögrenâs syndrome, the old and the new, Best Practice & Research Clinical Rheumatology, 2012, 26, 1, 105
- 3, , , , , Topical and systemic medications for the treatment of primary Sjögren's syndrome, Nature Reviews Rheumatology, 2012,
- 4, Recent developments in the diagnosis and management of Sjögrenâs syndrome, International Journal of Clinical Rheumatology, 2011, 6, 4, 445
- 5, , , , , , , Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome, Clinical & Experimental Immunology, 2011, 166, 3Direct Link:

1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
